Condition
Adjuvant Chemotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Adjuvant Chemotherapy clinical trials that are recruiting, in China. By phase: Phase 3 (4), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest Adjuvant Chemotherapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Plasma ctDNA methylation-guided adjuvant chemotherapy for stage I / low-risk stage II colorectal cancer | Phase 2 | Shanghai | Recruiting | May 1, 2026 |
| Comparing oxaliplatin plus S-1 versus docetaxel plus S-1 after surgery for stage III stomach cancer | Phase 3 | Shaoguan, Guandong and 4 other locations | Recruiting | Jan 26, 2026 |
| Neoadjuvant cadonilimab plus perioperative SOX for diffuse or mixed locally advanced stomach/GEJ cancer | Phase 3 | Lanzhou, Gansu and 3 other locations | Recruiting | Apr 29, 2025 |
| Comparing two treatment combinations for advanced gastric cancer | Phase 3 | Lanzhou, Gansu and 3 other locations | Recruiting | Apr 13, 2025 |
| Treatment for advanced cervical cancer using chemoradiotherapy and additional chemotherapy | Phase 3 | Liuzhou, Guangxi | Recruiting | Feb 21, 2023 |
| Evaluating the need for adjuvant chemotherapy in advanced colorectal cancer after preoperative treatment | — | Guangzhou, Guangdong | Recruiting | Nov 21, 2018 |
All recruiting trials (6)
-
Plasma ctDNA methylation-guided adjuvant chemotherapy for stage I / low-risk stage II colorectal cancer
This trial will test whether using a blood test for ctDNA methylation one month after surgery to guide adjuvant chemotherapy (such as capecitabine) helps clear ctDNA and lower recurrence risk in adults with stage I or low-risk stage II colorectal cancer who are ctDNA-positive.
-
Comparing oxaliplatin plus S-1 versus docetaxel plus S-1 after surgery for stage III stomach cancer
This trial tests whether oxaliplatin plus S-1 or docetaxel plus S-1 is better at preventing cancer recurrence in people with stage III gastric cancer after D2 gastrectomy.
-
Neoadjuvant cadonilimab plus perioperative SOX for diffuse or mixed locally advanced stomach/GEJ cancer
This will test whether adding cadonilimab to perioperative SOX chemotherapy helps people with diffuse or mixed locally advanced stomach or gastroesophageal junction adenocarcinoma.
-
Comparing two treatment combinations for advanced gastric cancer
This study is testing if adding a new drug called apatinib to standard treatments can help people with advanced gastric cancer get better results and stay safe during treatment.
-
Treatment for advanced cervical cancer using chemoradiotherapy and additional chemotherapy
This study is testing if adding extra chemotherapy to standard chemoradiotherapy can help people with advanced cervical cancer live longer and stay healthier.
-
Evaluating the need for adjuvant chemotherapy in advanced colorectal cancer after preoperative treatment
This study is testing if patients with advanced colorectal cancer who have already had treatment before surgery really need more chemotherapy afterward to stay cancer-free.
Related topics
Quick answers
How many Adjuvant Chemotherapy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 4, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.